Russell Pachynski

Russell Pachynski

Company: Washington University School of Medicine

Job title: Assistant professor, Division of Oncology


Altering the Human Prostate Tumor Immune Microenvironment Through Inhibition of Ibrutinib 12:00 pm

• This is the first clinical trial of the BTK inhibitor ibrutinib in prostate cancer • Ibrutinib may alter favorably alter the prostate tumor microenvironment by reducing pro-tumor B cells and increasing anti-tumor T cells • Inhibition of BTK may also limit tumor cell-intrinsic growth • Prostate tissue and peripheral correlative studies will be performed…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.